3 results match your criteria: "Australia (M.I.W.); and University of Adelaide[Affiliation]"
Response by Rao et al to Letter Regarding Article, "Effects of Arteriovenous Fistula Ligation on Cardiac Structure and Function in Kidney Transplant Recipients".
Circulation
November 2019
Adelaide Medical School, University of Adelaide, Australia (N.N.R., S.P.M., M.I.W., P.T.C.).
Effects of Arteriovenous Fistula Ligation on Cardiac Structure and Function in Kidney Transplant Recipients.
Circulation
June 2019
Adelaide Medical School, University of Adelaide, Australia (N.N.R., S.U., R.P.C., S.P.M., M.I.W., P.T.C.).
Background: Cardiovascular morbidity and mortality remain high in recipients of a kidney transplant. The persistence of a patent arteriovenous fistula (AVF) after transplantation may contribute to ongoing maladaptive cardiovascular remodeling. The ability to reverse this maladaptive remodeling by ligation of this AVF is unknown.
View Article and Find Full Text PDFCatheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.
Hypertension
September 2014
From the Veterans Affairs and Georgetown University Medical Centers, Washington, DC (V.P.); The First Cardiology Clinic, University of Athens, Ippokration Hospital, Athens, Greece (V.P., C.P.T.); Department of Cardiology, Flinders University, Bedford Park, Australia (A.S., D.P.C.); Monash Heart and Monash University, Melbourne, Australia (I.T.M., Y.M.); Royal Adelaide Hospital, Adelaide, Australia (M.I.W.); and University of Adelaide, Adelaide, Australia (S.G.W.).
Renal denervation has emerged as a novel approach for the treatment of patients with drug-resistant hypertension. To date, only limited data have been published using multielectrode radiofrequency ablation systems. In this article, we present the 12-month data of EnligHTN I, a first-in-human study using a multielectrode ablation catheter.
View Article and Find Full Text PDF